Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...

After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

A recent study highlights the alarming increase in death risk associated with respiratory syncytial virus (RSV) among adults.

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

In a new cross-sectional analysis of 6,746 hospitalized adults aged 60 and older in 20 states, increased respiratory ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...